CAD - Coronary Artery Disease, Chronic Total Occlusion (CTO), Triglycerid Glucose Index
Conditions
Brief summary
We retrospectively analyzed 200 CAD patients undergoing coronary angiography between 2026-2027. Patients were grouped by CTO presence. Clinical and laboratory parameters were compared, and logistic regression was performed to identify independent predictors.
Interventions
As no previous studies have demonstrated the predictive value of the TyG index for chronic total occlusion (CTO), the present investigation provides a novel contribution to the literature. We hypothesize that the triglyceride-glucose (TyG) index will be significantly higher in patients with chronic total occlusion (CTO) compared to those without CTO.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults ≥18 years of age, patients undergoing coronary angiography, non-obese individuals
Exclusion criteria
* Patients \<18 years of age, history of atrial fibrillation, pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease, obesity (BMI \>30 kg/m²), inaccessible patient records
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be the difference in the triglyceride-glucose (TyG) index between patients with chronic total occlusion (CTO) and those without CTO, assessed from routinely obtained blood samples. | 1 Year |
Countries
Turkey (Türkiye)